Response summary
Response . | R-CHOP, no. (%) . | CHOP, no. (%) . |
|---|---|---|
| Complete response | 49 (49.5) | 21 (41.2) |
| CRu | 8 (8.1) | 3 (5.9) |
| Total CR | 57 (57.6) | 24 (47.0) |
| Partial response | 8 (8.1) | 4 (7.8) |
| Progression | 8 (8.1) | 11 (21.6) |
| Stable | 8 (8.1) | 4 (7.8) |
| Unevaluable | 18 (18.2) | 7 (13.7) |
| Adverse event | 8 (8) | 1 (2) |
| Death | 6 (6) | 1 (2) |
| Patient withdrawal | 3 (3) | 1 (2) |
| Loss/noncompliance | 0 (0) | 3 (6) |
| Physician decision | 1 (1) | 1 (2) |
Response . | R-CHOP, no. (%) . | CHOP, no. (%) . |
|---|---|---|
| Complete response | 49 (49.5) | 21 (41.2) |
| CRu | 8 (8.1) | 3 (5.9) |
| Total CR | 57 (57.6) | 24 (47.0) |
| Partial response | 8 (8.1) | 4 (7.8) |
| Progression | 8 (8.1) | 11 (21.6) |
| Stable | 8 (8.1) | 4 (7.8) |
| Unevaluable | 18 (18.2) | 7 (13.7) |
| Adverse event | 8 (8) | 1 (2) |
| Death | 6 (6) | 1 (2) |
| Patient withdrawal | 3 (3) | 1 (2) |
| Loss/noncompliance | 0 (0) | 3 (6) |
| Physician decision | 1 (1) | 1 (2) |
Total patients treated with R-CHOP, 99; with CHOP, 50.